Long-term stimulant for methamphetamine recovery
Part of Mental health clinical trials.
This study tests whether a high dose of a stimulant medication (lisdexamfetamine, an ADHD medicine) taken over many weeks can help people who have already completed a methamphetamine treatment program to stay off meth, reduce use, or avoid relapse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- You have moderate to severe methamphetamine use disorder and have finished the earlier ASCME study with ongoing meth use, cravings, or high relapse risk
- You have no serious heart, blood pressure, thyroid, or other unstable medical conditions that stimulants might worsen
- You do not have a history of bipolar disorder, schizophrenia, or psychosis that would make the study unsafe
- If you can become pregnant, you must have a negative pregnancy test and use reliable birth control; you cannot be pregnant or nursing
- You are willing to be randomly assigned to one of two treatment groups and follow the study plan for the full length of the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests high-dose lisdexamfetamine (a prescription stimulant) to help people reduce or stop methamphetamine use. It also uses “contingency management” (rewards tied to meeting goals) to encourage treatment participation and lower use.
This study tests whether a medication called troriluzole can help people who use methamphetamine. If you have methamphetamine use disorder and are not seeking treatment right now, this study may be an option for you.
This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.
This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.
This trial tests a single dose of an investigational drug, CS-1103, to see if it is safe and effective for people who use methamphetamine. It may help understand how the drug affects methamphetamine in the body.
This study tests a support program for people with heart failure who also use methamphetamine and want to quit. It aims to improve both heart health and recovery from substance use.
Hear when a new Methamphetamine Abuse trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.